UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000003806
Receipt No. R000004178
Scientific Title Th1 related molecule in Behcet's disease
Date of disclosure of the study information 2010/06/23
Last modified on 2019/12/30 (Ver. 8)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Th1 related molecule in Behcet's disease
Acronym Behcet's disease and Th1 molecule
Scientific Title Th1 related molecule in Behcet's disease
Scientific Title:Acronym Behcet's disease and Th1 molecule
Region
Japan

Condition
Condition Behcet's disease
Classification by specialty
Clinical immunology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study has designed to investigate the role of Th1/Th17 related cytokines and signal molecules in Behcet's disease.
Basic objectives2 Bio-equivalence
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes New analysis to the pathogenesis of Behcet's disease from the view of Th1/Th17 cells
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients fulfilled the diagnostic criteria proposed by the International Study Group.
Key exclusion criteria None
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Noboru
Middle name
Last name Suzuki
Organization St. Marianna University School of Medicine
Division name Department of Immunology and Medicine
Zip code 216-8511
Address Sugao 2-16-1, Miyamae-ku, Kawasaki-shi, 216-8511, Japan
TEL 044-977-8111
Email n3suzuki@marianna-u.ac.jp

Public contact
Name of contact person
1st name Jun
Middle name
Last name Shimizu
Organization St. Marianna University School of Medicine
Division name Department of Immunology and Medicine
Zip code 216-8511
Address Sugao 2-16-1, Miyamae-ku, Kawasaki-shi, 216-8511, Japan
TEL 044-977-8111
Homepage URL
Email jshimizu@marianna-u.ac.jp

Sponsor
Institute St. Marianna University School of Medicine
Institute
Department

Funding Source
Organization MHLW (Japan)
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization St. Marianna University School of Medicine
Address Sugao 2-16-1, Miyamae-ku, Kawasaki-shi, 216-8511, Japan
Tel 044-977-8111
Email k-sienbu.mail@marianna-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2010 Year 06 Month 23 Day

Related information
URL releasing protocol
Publication of results Partially published

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2010 Year 06 Month 01 Day
Date of IRB
2005 Year 02 Month 01 Day
Anticipated trial start date
2010 Year 06 Month 01 Day
Last follow-up date
2027 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information We will observe Th1 and Th17 responces in peripheral blood mononuclear cells or tissues with Behcet disease. Case control sampling.

Management information
Registered date
2010 Year 06 Month 23 Day
Last modified on
2019 Year 12 Month 30 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000004178